Telomere syndrome
MONDO:0100137Accelerated aging syndromes often caused by inheritable gene mutations resulting in decreased telomere lengths.
Also known as: STS, short telomere syndrome
92 clinical trials for this condition and its sub-types, 9 tagged with Telomere syndrome itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Telomere syndrome
-
Cirrhosis, familial 4 trials · 79 incl. sub-types
3 sub-types
- Primary biliary cholangitis 74 trials Sub-types →
- Isolated congenital hepatic fibrosis 2 trials
- Cirrhosis, familial, with antigenemia 0 trials
-
4 sub-types
- Immunodeficiency-centromeric instability-facial anomalies syndrome 1 0 trials
- Immunodeficiency-centromeric instability-facial anomalies syndrome 2 0 trials
- Immunodeficiency-centromeric instability-facial anomalies syndrome 3 0 trials
- Immunodeficiency-centromeric instability-facial anomalies syndrome 4 0 trials
-
9 sub-types
- Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 7 0 trials
- Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 8 0 trials
- Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 9 0 trials
- Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1 0 trials
- Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2 0 trials
- Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3 0 trials
- Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 4 0 trials
- Pulmonary fibrosis and/or bone marrow failure, telomere-related, 5 0 trials
- Pulmonary fibrosis and/or bone marrow failure, telomere-related, 6 0 trials
-
2 sub-types
- ACD-related long telomere syndrome 0 trials
- ACD-related short telomere syndrome 0 trials Sub-types →
-
Coats plus syndrome 0 trials
Most studied deeper sub-types
-
Experimental infusion aims to fix bone marrow failure in rare telomere disease
Disease control OngoingThis early-stage trial tests a single infusion of EXG34217 in 12 people aged 12 and older who have bone marrow failure due to telomere biology disorders. The main goal is to check safety and tolerability, while also looking at changes in telomere length and blood cell counts. Bec…
Phase 1 • Sponsor: Elixirgen Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Gene study aims to unlock secrets of progressive lung disease
Knowledge-focused OngoingThis study follows 250 Italian adults with genetic forms of pulmonary fibrosis to see how their lung function changes over time. Researchers will track breathing tests and compare patients who receive immune-modulating drugs with those who do not. The goal is to understand how in…
Sponsor: Istituto Clinico Humanitas • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC